These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5787150)

  • 21. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
    Koopen NR; Wolters H; Havinga R; Vonk RJ; Jansen PL; Müller M; Kuipers F
    Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biliary excretion of morphine-3-glucuronide and morphine-3-ethereal sulfate by different pathways in the rat.
    Peterson RE; Fujimoto JM
    J Pharmacol Exp Ther; 1973 Feb; 184(2):409-18. PubMed ID: 4688177
    [No Abstract]   [Full Text] [Related]  

  • 23. Biliary and urinary metabolites of intravenously and intraduodenally administered 17 -oestradiol and oestriol.
    Stoa KF; Skulstad PA
    Steroids Lipids Res; 1972; 3(5):299-314. PubMed ID: 4661162
    [No Abstract]   [Full Text] [Related]  

  • 24. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis.
    Sánchez Pozzi EJ; Crocenzi FA; Pellegrino JM; Catania VA; Luquita MG; Roma MG; Rodríguez Garay EA; Mottino AD
    J Pharmacol Exp Ther; 2003 Jul; 306(1):279-86. PubMed ID: 12663690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of bile acids in the effect of ethinylestradiol on the biliary excretion of exogenous organic anions.
    Pfeifenróth A; Fischer E; Varga F
    Arch Toxicol Suppl; 1985; 8():342-4. PubMed ID: 3868362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of ethinylestradiol and epomediol on bile flow and biliary lipid composition in rat.
    Rodriguez JV; Torres AM; Lunazzi G; Tiribelli C
    Biochem Pharmacol; 1992 Mar; 43(6):1289-93. PubMed ID: 1562282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of organic anions on the biliary excretion of tri (14C) methyl-(3-hydroxyphenyl) ammonium O-glucuronide.
    Calvey TN; Back DJ
    Biochem J; 1971 Feb; 121(3):41P-42P. PubMed ID: 5119776
    [No Abstract]   [Full Text] [Related]  

  • 28. Lithocholate glucuronide is a cholestatic agent.
    Oelberg DG; Chari MV; Little JM; Adcock EW; Lester R
    J Clin Invest; 1984 Jun; 73(6):1507-14. PubMed ID: 6547150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The kinetics of hepatocellular transport and metabolism of estrogens (comparison between estrone sulfate, estrone and ethinylestradiol).
    Schwenk M; del Pino VL; Bolt HM
    J Steroid Biochem; 1979 Jan; 10(1):37-41. PubMed ID: 513716
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of iron overload on bile secretion and hepatic porphyrin metabolism in ethinyl estradiol-treated rats.
    Cantoni L; Di Padova C; Rizzardini M; Dal Fiume D; Graziani A; Rovagnati P; Tritapepe R
    Toxicology; 1986 Feb; 38(2):187-96. PubMed ID: 3945969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estradiol metabolism in total extrahepatic biliary obstruction.
    Hellman L; Zumoff B; Fishman J; Gallagher TF
    J Clin Endocrinol Metab; 1970 Feb; 30(2):161-5. PubMed ID: 5413647
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of 17alpha-ethinylestradiol on biliary excretion of bile acids.
    Watanabe H
    Biochim Biophys Acta; 1975 Jul; 399(1):79-84. PubMed ID: 1148281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis.
    Muchova L; Vanova K; Suk J; Micuda S; Dolezelova E; Fuksa L; Cerny D; Farghali H; Zelenkova M; Lenicek M; Wong RJ; Vreman HJ; Vitek L
    J Cell Mol Med; 2015 May; 19(5):924-33. PubMed ID: 25683492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biliary excretion kinetics of phenolphthalein glucuronide after intravenous and retrograde biliary administration.
    Gustafson JH; Benet LZ
    J Pharm Pharmacol; 1974 Dec; 26(12):937-44. PubMed ID: 4156858
    [No Abstract]   [Full Text] [Related]  

  • 35. Ethynylestradiol-induced impairment of bile secretion in the rat: protective effects of S-adenosyl-L-methionine and its implication in estrogen metabolism.
    Stramentinoli G; Di Padova C; Gualano M; Rovagnati P; Galli-Kienle M
    Gastroenterology; 1981 Jan; 80(1):154-8. PubMed ID: 7450400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatotoxic effects of estradiol-17 beta-D-glucuronide in the rat and monkey.
    Slikker W; Vore M; Bailey JR; Meyers M; Montgomery C
    J Pharmacol Exp Ther; 1983 Apr; 225(1):138-43. PubMed ID: 6300372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biliary excretion of estradiol-17 beta-glucuronide in the rat.
    Takikawa H; Yamazaki R; Sano N; Yamanaka M
    Hepatology; 1996 Mar; 23(3):607-13. PubMed ID: 8617443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biliary metabolites of estriol in the rat.
    Menzies JA; Watanabe H
    Steroids; 1976 May; 27(5):595-601. PubMed ID: 941179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholestasis induced by lithocholate and its glucuronide: their biliary excretion and metabolism.
    Takikawa H; Ohki H; Sano N; Kasama T; Yamanaka M
    Biochim Biophys Acta; 1991 Jan; 1081(1):39-44. PubMed ID: 1991154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts.
    Utili R; Tripodi MF; Adinolfi LE; Gaeta GB; Abernathy CO; Zimmerman HJ
    Hepatology; 1990 May; 11(5):735-42. PubMed ID: 2347547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.